Get started
Author

Mujahid A. Rizvi

T-cell non-Hodgkin lymphoma
2005 · Mujahid A. Rizvi, Andrew M. Evens, et al. · Blood · 224
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004 · Sara K. Vesely, Jedidiah J. Perdue, et al. · Annals of Internal Medicine · 130
The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT Pathway
2006 · Christiane Querfeld, Mujahid A. Rizvi, et al. · Journal of Investigative Dermatology · 89
Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
2006 · Mujahid A. Rizvi, Kulsoom Ghias, et al. · Molecular Cancer Therapeutics · 81
PDF
Drug-Induced Thrombocytopenia: An Updated Systematic Review
2001 · Mujahid A. Rizvi, Kiarash Kojouri, et al. · Annals of Internal Medicine · 41
A call to action to advance patient‐focused and decentralized clinical trials
2024 · R. Donald Harvey, Therica M. Miller, et al. · Cancer · 29
PDF
Drug-induced thrombocytopenia
1999 · Mujahid A. Rizvi, Shehla Rizvi Shah, et al. · Current Opinion in Hematology · 25
Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement
2024 · Ramya Thota, Patricia A. Hurley, et al. · Journal of Clinical Oncology · 21
PDF
Enzastaurin (LY317615), an Oral Protein Kinase C β Inhibitor, Induces Apoptosis in Multiple Myeloma Cell Lines.
2005 · Mujahid A. Rizvi, Kulsoom Ghias, et al. · Blood · 5
T-cell lymphoma
2001 · Mujahid A. Rizvi, Andrew M. Evens, et al. · Cambridge University Press eBooks
Works count: 10
Citation count: 645
H-index: 8
I10-index: 8
Year
Topic
Type